SC
WST icon

Steven Cohen’s West Pharmaceutical WST Stock Holding History

Steven Cohen’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102M Buy
283,396
+124,046
+78% +$37.9M 0.11% 200
2026
Q1 		$39.9M Sell
159,350
-75,687
-32% -$18.8M 0.05% 468
2025
Q4 		$64.7M Sell
235,037
-424,216
-64% -$116M 0.07% 315
2025
Q3 		$173M Buy
659,253
+319,300
+94% +$77.6M 0.29% 51
2025
Q2 		$74.4M Buy
339,953
+211,666
+165% +$45.2M 0.15% 167
2025
Q1 		$28.7M Sell
128,287
-74,185
-37% -$20.4M 0.07% 347
2024
Q4 		$66.3M Buy
+202,472
New +$63.7M 0.15% 158
2024
Q2 		– Sell
-112,107
Closed -$44.4M – 2522
2024
Q1 		$44.4M Buy
112,107
+4,516
+4% +$1.67M 0.11% 229
2023
Q4 		$37.9M Sell
107,591
-76,000
-41% -$26.9M 0.09% 272
2023
Q3 		$68.9M Buy
+183,591
New +$71M 0.2% 112
2023
Q2 		– Sell
-174,599
Closed -$60.5M – 2857
2023
Q1 		$60.5M Buy
174,599
+174,065
+32,596% +$50.9M 0.19% 135
2022
Q4 		$126K Buy
+534
New +$127K ﹤0.01% 1293
2021
Q4 		– Sell
-24,728
Closed -$10.5M – 1329
2021
Q3 		$10.5M Sell
24,728
-5,400
-18% -$2.28M 0.05% 475
2021
Q2 		$10.8M Sell
30,128
-16,729
-36% -$5.53M 0.05% 430
2021
Q1 		$13.2M Buy
46,857
+8,739
+23% +$2.5M 0.06% 362
2020
Q4 		$10.8M Sell
38,118
-23,591
-38% -$6.62M 0.05% 426
2020
Q3 		$17M Sell
61,709
-9,588
-13% -$2.54M 0.09% 304
2020
Q2 		$16.2M Buy
71,297
+41,316
+138% +$8.12M 0.11% 247
2020
Q1 		$4.57M Sell
29,981
-97,212
-76% -$15M 0.04% 394
2019
Q4 		$19.1M Buy
127,193
+90,195
+244% +$13.1M 0.1% 265
2019
Q3 		$5.25M Buy
36,998
+35,798
+2,983% +$4.93M 0.03% 446
2019
Q2 		$150K Buy
+1,200
New +$142K ﹤0.01% 1000

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Steven Cohen's WST Position: Q2 2026 in Review

Steven Cohen increased its West Pharmaceutical (WST) stake by 78% in Q2 2026, buying an estimated $37.9M and bringing the position to 283,396 shares worth $102M. The position accounts for 0.11% of the portfolio, ranked #200.

Steven Cohen first reported a position in WST in Q2 2019 and has held it in 22 quarters since. The position peaked at $173M in Q3 2025. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Steven Cohen held 283,396 shares of West Pharmaceutical worth $102M as of Q2 2026.
  • Steven Cohen bought 124,046 West Pharmaceutical shares in Q2 2026, an estimated $37.9M.
  • West Pharmaceutical made up 0.11% of Steven Cohen's portfolio in Q2 2026, its #200 holding.
  • Steven Cohen first reported a position in West Pharmaceutical in Q2 2019 and has held it in 22 quarters since.
  • Steven Cohen's West Pharmaceutical position peaked at $173M in Q3 2025.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.